Use Cord Blood Single Nucleotide Polymorphism to Predict the Later Development of Atopy and Allergy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2009 by Min-Sheng General Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
National Taiwan University Hospital
Information provided by:
Min-Sheng General Hospital
ClinicalTrials.gov Identifier:
NCT00444327
First received: March 6, 2007
Last updated: May 13, 2009
Last verified: May 2009
  Purpose

The aim of our study was firstly to detect in cord bloods the polymorphism of genes related to atopy and allergic diseases and to examine their mutual interaction and their associations with cord blood IgE and cytokines. After that, in the prospective follow-up visits, we liked to investigate if the measurement of cord blood SNPs of genes related to atopy and allergic diseases was helpful in predicting the development of atopy and allergic diseases later in life.


Condition
Atopy
Allergic Disease

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Observational Study of Cord Blood Single Nucleotide Polymorphisms of Genes Related to Atopy and Allergic Diseases

Resource links provided by NLM:


Further study details as provided by Min-Sheng General Hospital:

Estimated Enrollment: 900
Study Start Date: March 2007
  Eligibility

Ages Eligible for Study:   up to 1 Minute
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

hospital and primary care clinic based study

Criteria

Inclusion Criteria:

  • Apgar score of 5 minutes not less than 7 gestational age not less than 36 weeks

Exclusion Criteria:

  • Apgar score of 5 minutes < 7 gestational age < 36 weeks
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00444327

Contacts
Contact: Chien-Han Chen, M.D. 886-3-3179599 ext 2007 chinsword@yahoo.com.tw

Locations
Taiwan
Min-Sheng General Hospital Not yet recruiting
Taoyuan, Taiwan
Principal Investigator: Chien-Han Chen, M.D.         
Min-Sheng General Hospital Recruiting
Taoyuan, Taiwan
Sponsors and Collaborators
Min-Sheng General Hospital
National Taiwan University Hospital
Investigators
Principal Investigator: Chien-Han Chen, M.D. Min-Sheng General Hospital
  More Information

No publications provided

Responsible Party: Chien-Han Chen, Min-Sheng General Hospital
ClinicalTrials.gov Identifier: NCT00444327     History of Changes
Other Study ID Numbers: 2007005
Study First Received: March 6, 2007
Last Updated: May 13, 2009
Health Authority: Taiwan: Institutional Review Board

Keywords provided by Min-Sheng General Hospital:
single nucleotide polymorphism

ClinicalTrials.gov processed this record on October 19, 2014